We are pleased to announce the launch of FLD SpO2. Due to numerous requests for a detailed installation guide for the application, we have provided the necessary information below. The application can be obtained from our exclusive app store, the “SFM App Store.” Access the SFM App Store here. SFM App Store To use the …
Read more “Instructions for Installing the FLD App (FLD SpO2/FLD HbA1c)”
Our company began releasing the FLD HbA1c from the SFM App Store at the end of September 2025. From the end of October 2025, we initiated international releases and are currently distributing in 18 countries, including Japan. We are pleased to announce the upcoming launch of the ‘FLD SpO2,’ which is capable of estimating oxygen …
Read more “Regarding the Release of the New Product “FLD SpO2””
I am pleased to report that I participated in the completion ceremony for the new main building held on December 9, 2025. The ceremony was attended by key figures from the University of Tokyo, including the University President and the Director of the Institute for Quantitative Biosciences (IQB), among others. The ribbon-cutting ceremony Our company …
Our company has been engaged in the development of measurement technology for completely non-contact, non-invasive blood testing information based on mathematical sciences for over a decade. On August 29, 2025, we will present our technology at the national conference of the Japanese Society of Laboratory Medicine. Starting from the end of September 2025, we will …
Read more “The iOS version of the LDL cholesterol app has been completed.”
Our company presented a study on the non-contact, non-invasive measurement of HbA1c at the Annual Meeting of the Japan Society of Clinical Chemistry held on August 29, 2025. By the end of September 2025, we released an Android application, “FLD HbA1c,” through the SFM App Store, and we are currently offering the app in 18 …
Read more “Exhibition/Presentation at the Medical Conference Forum”
We have released “FLD HbA1c” on our app store, “SFM App Store,” since the end of September 2025. With increasing attention from overseas, we have significantly revamped our website on December 2, 2025, to enable global accessibility. In 2026, we aim to further contribute to the world with presentations on LDL cholesterol at academic conferences, …
For over ten years, our company has been developing technology for completely non-contact and non-invasive blood test information measurement, grounded in mathematical and neuroscientific principles. On August 29, 2025, we will present our technology at the Annual Meeting of the Japanese Association of Clinical Laboratory Medicine, and starting from the end of September 2025, we …
Read more “The Android version of the LDL Cholesterol App has been completed.”
After extensive foundational research, SFM Corporation independently developed the Android app “FLD HbA1c,” which was launched in seven countries across Southeast and Southwest Asia on October 22, 2025. Subsequently, it was released in five countries within the Asia-Oceania region on November 3, 2025, and in four countries within the Asia-Central America region on November 16, …
Read more “We have increased the number of foreign countries where FLD HbA1c is available.”
Since the end of September 2025, we have been releasing our independently developed FLD HbA1c app on the SFM App Store, following many years of foundational research. This app adopts a subscription model. Given the increasing issues related to subscription cancellations in recent years, we would like to take this opportunity to explain our cancellation …
The Life Biomedical Science Advisors and Sub-Advisors will be involved in the development and research of new fields related to our future-oriented advanced technologies. We are delighted to welcome TEMIZOZ Burcu, a promising researcher and Assistant Professor at the Institute of Medical Science, The University of Tokyo, to join us as a Life Science Sub-Advisor. …